Increasing the Number of HIV Diagnostics Test is expected to drive the Growth of the Global HIV Diagnostics Test Market

 

HIV Diagnostics Test Market
HIV Diagnostics Test Market

HIV preventive strategies include testing and counselling for sexually transmitted infections (STIs) and HIV, preventing mother-to-child transmission, and using treatments and antiretroviral medications. The introduction of Point-of-Care (POC) testing for HIV detection has resulted in the healthcare industry harnessing new advances in POC devices through research and development. POC devices are simple to use and maintain, and they may be carried easily. Antiretroviral therapy (ART), Cluster of Differentiation 4 (CD4) tests, HIV Rapid Diagnostic Tests (RDTs), Viral Load (VL) testing, and HIV early-infant diagnostic tests have all come from recent advances in POC testing.

Since the beginning of the COVID-19 pandemic, the Egyptian government has made enormous investments in providing health services to all patients, particularly those with chronic conditions such as AIDS. Furthermore, according to the Ministry of Health Saudi Arabia, the MoH would spend around US$ 71 billion in 2020 on healthcare awareness campaigns in Saudi Arabia.

Key market participants are focused on the development and marketing of technologically enhanced HIV diagnostics tests in order to grow their product range and worldwide HIV Diagnostics Test market presence. For example, F. Hoffmann-La Roche AG, a Swiss global healthcare business, debuted the Elecsys HIV Duo immunoassay in the United States in 2020 after receiving FDA approval in April 2020. Elecsys HIV Duo is the first 4th generation HIV testing system in the United States to detect HIV p24 antigen and anti-HIV antibodies separately.

Comments

Popular posts from this blog

The Role of the Foodservice Industry in Driving the French Fries Market

Market Share and Revenue Analysis of the Microdermabrasion Devices Market

The Growing Demand for Healthcare Staffing Market: Trends and Opportunities